Quidel Corp (QDEL) – Strategy, SWOT and Corporate Finance Report

Quidel Corp (QDEL) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Quidel Corp (Quidel) is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions for the detection and diagnosis of critical diseases and other medical conditions. Its major products include immunoassays, molecular assays, virology products including traditional cell lines, specimen collection devices, media and controls; and specialty products including metabolic bone markers and enzyme linked immunosorbent assays (ELISA) and reagents. The company offers its products to physician offices, hospitals, clinical and reference laboratories, universities, retail clinics, urgent care clinics, pharmacies and wellness screening centers. It distributes products through direct sales force and a network of national and regional distributors. It has presence in the US, Ireland and China, among others. Quidel is headquartered in San Diego, California, the US.

Scope

• Detailed information on Quidel Corp required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Quidel Corp in the form of a SWOT analysis

• An in-depth view of the business model of Quidel Corp including a breakdown and examination of key business segments

• News about Quidel Corp, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Quidel Corp and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Quidel Corp as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Quidel Corps business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Meridian Bioscience Inc

Alere Inc

Cepheid Inc

Sekisui Medical Co Ltd

Abbott Laboratories

Thermo Fisher Scientific Inc

Becton Dickinson and Co

Beckman Coulter Inc

Danaher Corp

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Quidel Corp - Key Facts

Quidel Corp - Key Employees

Quidel Corp - Key Employee Biographies

Quidel Corp - Major Products and Services

Quidel Corp - History

Quidel Corp - Company Statement

Quidel Corp - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Quidel Corp - Business Description

Product Category: Cardiometabolic Immunoassay

Overview

Performance

Product Category: Molecular Diagnostic Solutions

Overview

Performance

Product Category: Rapid Immunoassay

Overview

Performance

Product Category: Specialized Diagnostic Solutions

Overview

Performance

Geographical Segment: Domestic

Performance

Geographical Segment: Foreign

Performance

R&D Overview

Quidel Corp - Corporate Strategy

Quidel Corp - SWOT Analysis

SWOT Analysis - Overview

Quidel Corp - Strengths

Quidel Corp - Weaknesses

Quidel Corp - Opportunities

Quidel Corp - Threats

Quidel Corp - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Quidel Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Quidel Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022

Quidel Corp, Recent Deals Summary

Section 5 – Company’s Recent Developments

Apr 07, 2022: Quidel Announces Preliminary Revenue for First Quarter 2022

Feb 17, 2022: Quidel Reports Fourth Quarter and Full Year 2021 Financial Results

Jan 07, 2022: Quidel Announces Preliminary Revenue for Fourth Quarter 2021

Jan 05, 2022: The signs, diagnosis and treatment of lyme disease discussed as part of new, on-demand webinar hosted by industry-leading Quidel

Dec 24, 2021: Quidel signs deal to buy Ortho Clinical Diagnostics for $6bn

Nov 04, 2021: Quidel Reports Third Quarter 2021 Financial Results

Oct 07, 2021: Quidel Announces Preliminary Revenue for Fiscal Third Quarter 2021

Aug 05, 2021: Quidel Reports Second Quarter 2021 Financial Results

Jul 27, 2021: Beckman Coulter and Quidel resolve legal dispute over BNP Business

Jul 26, 2021: Quidel announces agreement with Beckman Coulter that terminates ongoing litigation and transitions BNP business to Beckman Coulter

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Quidel Corp, Key Facts

Quidel Corp, Key Employees

Quidel Corp, Key Employee Biographies

Quidel Corp, Major Products and Services

Quidel Corp, History

Quidel Corp, Other Locations

Quidel Corp, Subsidiaries

Quidel Corp, Key Competitors

Quidel Corp, Ratios based on current share price

Quidel Corp, Annual Ratios

Quidel Corp, Annual Ratios (Cont…1)

Quidel Corp, Annual Ratios (Cont…2)

Quidel Corp, Interim Ratios

Quidel Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Quidel Corp, Medical Equipment, Deals By Type, 2016 to YTD 2022

Quidel Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Quidel Corp, Performance Chart (2017 – 2021)

Quidel Corp, Ratio Charts

Quidel Corp, Medical Equipment, Deals By Year, 2016 to YTD 2022

Quidel Corp, Medical Equipment, Deals by Type, 2016 to YTD 2022

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports